Computational Tools to Assess the Functional Consequences of Rare and Noncoding Pharmacogenetic Variability

Area of Science:

• Pharmacogenomics
• Computational Biology
• Genetics

Background:

• Interindividual differences in drug response are a significant challenge in medicine.
• Known genetic factors explain only a portion of heritable variability in drug response and toxicity.
• Vast numbers of pharmacogenetic variants with unknown functional effects have been identified.

Purpose of the Study:

• To review and critically assess computational variant effect predictors for pharmacogenomics.
• To discuss the utility of these tools for predicting drug response and toxicity.
• To highlight the need for improved predictive accuracy in personalized pharmacogenomics.

Main Methods:

• Review of current state-of-the-art computational variant effect predictors.
• Discussion of prediction methods for various variant classes (missense, synonymous, splice, noncoding).
• Exploration of emerging methods for assessing haplotypes and structural variations.

Main Results:

• Conventional prediction methods based on evolutionary conservation have limitations, especially for poorly conserved pharmacogenes.
• Progress has been made in evaluating non-coding and synonymous variations, but challenges remain.
• New approaches are needed to improve the predictive accuracy of variant effect predictors.

Conclusions:

• Translating genetic variant data into actionable clinical insights for drug response remains a major challenge.
• Development of algorithms trained on pharmacogenomic data is crucial for improving predictive accuracy.
• Enhanced computational tools are essential for advancing precision pharmacogenomics and clinical decision support.